SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

GLSI is trending due to positive data showing a significant reduction in breast cancer recurrence rates, sparking both excitement and skepticism within the community. While bulls point to the potential for a major breakthrough and high short interest creating squeeze potential, bears express concerns about the methodology of the study and potential dilution. The community is closely watching for further developments, particularly regarding interim analysis and potential partnerships.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending amidst discussions about its valuation, potential for full self-driving capabilities, and analyst expectations, including bullish forecasts from Dan Ives. The community is debating whether the current stock price reflects fundamentals or if it's driven by hype and future possibilities like robotaxis and AI advancements. Additionally, some are discussing potential competition from other EV companies and advancements in autonomous driving technology.

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

LASR is trending as investors discuss its potential role in defense contracts, particularly the "Golden Dome" initiative. The community is weighing the company's technology and market position, with some suggesting it's undervalued, while others point to near-term risks. Some see parallels with other defense stocks, anticipating a potential breakout if contracts materialize.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to speculation around a potential short squeeze, driven by its low float and recent price action; the community is watching key breakout levels. Bullish sentiment is fueled by comparisons to other low-float runners, though some caution against potential volatility and the risk of dilution. Chatter also mentions potential news catalysts and a signed AI + blockchain deal.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

401JK is trending as community members rally around its anti-establishment narrative, promoting it as an alternative to traditional retirement plans. Discussions highlight the project's strong holder base, upcoming staking features, and a vision that challenges the traditional finance system. Despite overall market volatility, community members express conviction in the project's long-term potential as a movement.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is trending due to positive Phase 2 trial results for its stiff person syndrome treatment, with the community highlighting statistically significant improvements in patient mobility. Analyst upgrades and increased attention on social media indicate growing bullish sentiment, though some caution remains around biotech risk and potential sell-the-news dynamics. The company's connection to Stiff Person Syndrome is also driving interest.

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Immunome Inc

Immunome ($IMNM) is trending due to positive Phase 3 trial results for its desmoid tumor treatment, varegacestat, with investors closely monitoring endpoints like PFS and ORR. Community discussions revolve around the data's implications and comparisons to existing treatments. The company is also considering regulatory approval submissions and commercialization plans.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending amid talks of acquiring cybersecurity firm Armis for a potential $7 billion, which would be its largest deal yet, as it looks to bolster its security offerings. While some analysts are adjusting their ratings, the community is weighing the potential benefits of strengthening its portfolio in the connected device (IoT, OT, IT) security space. Community members also discussed the recent shareholder approval of a 5-for-1 stock split.

Mask Network is the core product of Dimension, which is positioned to become the bridge that connects internet users from Web 2.0 to Web 3.0. The foundational technology of Mask Network is a peer-to-peer encrypted messaging application, with new functions continuously being created around this foundation. We at Mask Network are strong believers in the ownership economy. People should own what they produce, people should own their data, their attention and the virtual space they choose to contribute to.  Mask Network integrates decentralized social messaging, borderless payment network, and decentralized file storage and sharing to provide a safe and convenient portal for users to jump right into the continent of decentralized finance and then the new world of Web 3.0.

Mask Network

MASK is trending as traders discuss its potential within the Web3 space, particularly following its recent price surge. Community members are analyzing technical indicators and speculating on future price movements, with some pointing to a limited supply and increased volume as bullish signals. The broader conversation revolves around MASK's role in decentralized social media and its potential for further growth.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that the U.S. government may ease restrictions on marijuana, with reports suggesting executive action could be taken soon. The cannabis community is actively discussing potential short squeezes and the possibility of significant gains if the rumored policy changes materialize. Investors are weighing the potential for a 'sell-the-news' event against the broader implications of regulatory shifts for the cannabis sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Redmile Group LLC Sells 102,106 Shares of IDEAYA Biosciences, Inc. $IDYA

Redmile Group LLC reduced its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 19.1% during the 2nd quarter, according to its most recent disclosure with the Securities and...

IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA*A2-Negative Metastatic Uveal Melanoma

IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA*A2-Negative Metastatic Uveal...

Stempoint Capital LP Purchases 98,886 Shares of IDEAYA Biosciences, Inc. $IDYA

Stempoint Capital LP grew its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 147.6% in the second quarter, according to the company in its most recent 13F filing with...

IDEAYA Biosciences Announces IND Submission for IDE574, a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers

IDEAYA Biosciences Announces IND Submission for IDE574, a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers IDEAYA Biosciences Announces IND Submission for IDE574, a...

Hsbc Holdings PLC Has $804,000 Stake in IDEAYA Biosciences, Inc. $IDYA

Hsbc Holdings PLC reduced its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 55.7% during the second quarter, according to the company in its most recent 13F filing with the...

JPMorgan Chase & Co. Purchases 115,827 Shares of IDEAYA Biosciences, Inc. $IDYA

JPMorgan Chase & Co. raised its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 35.0% during the second quarter, according to its most recent disclosure with the...

IDEAYA Biosciences (NASDAQ:IDYA) Reaches New 52-Week High - Here's Why

IDEAYA Biosciences (NASDAQ:IDYA) Sets New 52-Week High - What's Next...

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have received an average rating of "Moderate Buy" from the seventeen ratings firms that are covering the company, MarketBeat.com...

IDEAYA Biosciences (NASDAQ:IDYA) Hits New 52-Week High - Time to Buy?

IDEAYA Biosciences (NASDAQ:IDYA) Reaches New 12-Month High - Should You Buy...

IDEAYA Biosciences Announces IND Clearance for IDE034, a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types

IDEAYA Biosciences Announces IND Clearance for IDE034, a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types IDEAYA Biosciences Announces IND Clearance for...

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. It focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

IDYA
Ideaya Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IDYA News

IDYAIdeaya Biosciences Inc